Special characteristics of topical treatment in children;Besonderheiten der topischen behandlung im kindesalter

Hautarzt

Volumn 49, Issue 3, 1998, Pages 170-175

  Werfel, Sabine ^a,b   Boeck, Kerstin ^a   Abeck, Dietrich ^a   Ring, Johannes ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Atopic eczema; Skin physiology; Stratum corneum; Topical treatment

Indexed keywords

BORIC ACID; EMLA; GLUCOCORTICOID; HEXACHLOROPHENE; PHENOL; SALICYLIC ACID; UREA;

ARTICLE; ATOPIC DERMATITIS; DRUG PENETRATION; ECZEMA; HUMAN; MOLLUSCUM CONTAGIOSUM; SKIN PERMEABILITY; STRATUM CORNEUM; TOPICAL DRUG ADMINISTRATION; TOPICAL TREATMENT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ERUPTIONS; HUMANS; INFANT; INFANT, NEWBORN; SKIN; SKIN ABSORPTION;

EID: 0031921397     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050050723     Document Type: Article

References (51)

1. Armoni M, Bibi H, Schlesinger M, Pollak S, Metzker A (1988) Pediculosis capitis: why prefer a solution to shampoo or spray. Pediatr Dermatol 5 273-275
2. Bjerring P, Arent-Nielsen L (1990) Depth and duration of skin analgesia to needle insertion after topical application of EMLA cream. Br J Anaesth 64:173-177
3. Braun-Falco O, Plewig G, Wolff HH (1996) Äußerliche Dermatotherapie. In: Braun-Falco O, Plewig G,Wolff HH (Hrsg) Dermatologie und Venerologie. Springer, Berlin Heidelberg New York, S 1527
4. Bjornberg A, Molacken A (1972) Necrotic skin reactions caused be 1% gentianviolet and brilliantgreen. Acta Derm Venerol (Stockh) 52:55
5. Benson PF, Pharoah POD (1960) Benign intracranial hypertension due to adrenal steroid therapy. Guy's Hospital Rep 109.212-218
6. Cunliffe WJ, Burton JL, Holti G (1975) Hazard of steroid therapy in hepatic failure. Br J Dermatol 93:183-185
7. Darmstadt GL, Lane AT (1994) Impetigo: an overview. Pediatr Dermatol 11.293-303
8. Ducey J, Brooke D (1953) Transcutaneous absorption of boric acid. J Pediatr 43:644-651
9. Evans N, Rutter N (1986) Development of the epidermis in the newborn. Biol Neonate 49:74-80
10. Feiwel M, Kelly WF (1974) Adrenal unresponsiveness associated with clobetasol propionate. (letter) Lancet (872) II:112-13
11. Gorter E (1949) On salicylate poisining in children. Acta Pediatr 38:170-177
12. Gutman AB, Yu TF, Sirota JH (1955) Study by simultaneous clearance techniques of salicylate excretion in man: effect of alkalinization of urine by bicarbonate administration; effect of probenecid. J Clin Invest 34:711-721
13. Hammarlund K, Sedin G (1979) Transepidermal water loss in newborn infants III. Relation to gestational age. Acta Peadiatr Scand 68:795-801
14. Harpin V, Rutter N (1983) Barrier properties of the newborn infant's skin. J Pediatr 102:419-425
15. Harpin V (1982) Sweating in preterm babies. J Pediatr 100:614-620
16. Harris JS (1957) Special pediatric problems in fluid and electrolyte therapy in surgery. Ann NY Acad Sci 66:966-975
17. Hepburn D, Yohn JJ, Weston WL (1994) Topical steroid treatment in infants, children, and adolescents. Advanc Dermatol 9:225-255
18. Hintner, Breathnach (1993) Unerwünschte Arzneimittelwirkungen an der Haut. Blackwell, Berlin, S 427
19. Hornstein OP, Nurnberg E (1985) Externe Therapie von Hautkrankheiten. Thieme, Stuttgart New York, S 225-236
20. Hosking GP, Elliston H (1978) Benign intracra-nial hypertension in a child with eczema treated with topical steroids. Br Med J 1:550-551
21. Juhlin L, Rollman O (1984) Vascular effects of a local anesthetic mixture in atopic dermatitis. Acta Derm Venereol (Stockh) 64:439-440
22. Keyworth N, Millar M, Holland K (1992) Development of cutaneous microflora in premature neonates. Arch Dis Child 67.797-801
23. Krafchik BR (1995) The use of topical steroids in children. Semin Dermatol 14:70-74
24. Lane AT (1987) Development and care of the premature infant's skin. Pediatr Dermatol 4:1-5
25. Lane AT, Drost SS (1993) Effects of repeated application of emollient cream to premature infant skin. Pediatrics 92:415-9
26. Leiferman KM, Schroeter A, Kirschner MK, Spelsberg TC (1983) Characterization of the glucocorticoid receptor in human skin. J Invest Dermatol 81:355-360
27. Maurer A, Micheli J, Schutz Y, Freymond D, Jequier E (1984) Transepidermal water loss and resting energy expenditure in preterm infants. Helv Paediatr Acta 39:405-418
28. Massarano AA, Hollis S, Devlin J (1993) Growth in atopic eczema. Arch Dis Child 68:677-679
29. Morselli PL (1976) Clinical pharmacokinetics in neonates. Clin Pharmacokinet 1:81-98
30. Niedner R (1993) Kortikosteroide bei Hautkrankheiten - externe und systemische Anwendung. Bayer Int 13:3-11
31. Nilson A, Engberg G, Henneberg S (1990) Inverse relationship between age-depen-dent erythrocytes activity of methaemoglobin reductase and prilocaine-induced methaemoglobinaemia during infancy. Br J Anaesth 64:72-76
32. Oranje AP, Waard-van der Spek FB de, Vuzevski VD (1990) Condylomata acuminata in children. Int J STD AIDS 1:250-255
33. Patrizi A, Lernia DL, Ricci G, Masi M (1990) Atopic background of a recurrent papular eruption of childhood (frictional lichenoid eruption). Pediatr Dermatol 7 11-15
34. Pramanik AK, Hansen RC (1979) Transcutaneous gamma benzene hexachloride absorption and toxicity in infants and children. Arch Dermatol 115:1224-1225
35. Queille C, Pommarede R, Saurat JH (1984) Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood. Pediatr Dermatol 1.246-253
36. Ring J, Frohlich HH (1985) Wirkstoffe in der dermatologischen Therapie. Springer, Berlin Heidelberg New York, S 202
37. Ring J (1988) Angewandte Allergologie. MMV, Munchen, Vieweg & Sohn-Braunschweig/Wiesbaden
38. Rogers SCF, Burrows D, Neill D (1978) Percutaneous absorption of phenol and methyl alcohol in magenta paint B.P.C. Br J Dermatol 98:559-60
39. Swanbeck G (1992) Urea in the treatment of dry skin. Acta Derm Venerol (Stockh) 177:7-8
40. Turpeinen M, Salo OP Leisti S (1986) Effects of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease. Br J Dermatol 115:475-484
41. Turpeinen M (1988) Influence of age and severity of dermatitis on the percutaneous absorption of hydrocortisone in children. Br J Dermatol 118:517-522
42. Turpeinen M, Leritokoski-Lehtiniemi E, Leisti S (1988) Percutaneous absorption of hydrocortison during and after the acute phase of dermatitis in children. Pediatr Dermatol 5:276-279
43. Tryala EE, Hillman LS, Hiliman RE, Dodson WE (1977) Clinical pharmacology of hexachlorophene in newborn infants. J Pediatr 9:481-486
44. Vernon HJ (1993) Advances in the care of neonatal skin. Curr Sci 123-126
45. Vernon HJ, Lane A, Wischerath L, Davis J, Menegus M (1990) Semipermeable dressing and transepidermal water loss in premature infants. Pediatr 86:357-362
46. Waard-van der Spek FB de, Oranje AB, Lillieborg S (1990) Treatment of molluscum contagiosum under analgesia with a lido-caine/prilocains cream (EMLA). J Am Acad Dermatol 23:685-688
47. Waard-van der Sepk FB de, van den Berg GM, Oranje AP (1992) EMLA cream: an improved local anesthetic. Review of current literature. Pediatr Dermatol 9:126-131
48. Weiss JF, Lever WF (1964) Percutaneous salicylic acid intoxication in psoriasis. Arch Dermatol 90:614-619
49. West D, Worobec S, Solomon L (1981) Pharmacology and toxicology of infant skin. J Invest Dermatol 76:147-150
50. Wohltab W (1992) Neurodermitis und Harnstoff. Hautarzt 2 [Suppl 11]: 1-4
51. WohlrabW (1984) Vehikelabhängigkeit der Harnstoffpenetration in die menschliche Haut. Dermatologica 169:53-59